Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease
Charles P Semba,1 Thomas R Gadek2 1Vascular and Interventional Radiology, Stanford University School of Medicine, Stanford, CA, USA; 2Ophthalma Logic Consulting, Park City, UT, USA Abstract: Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by symptoms of disco...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-06-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/development-of-lifitegrast-a-novel-t-cell-inhibitor-for-the-treatment--peer-reviewed-article-OPTH |